drugset / Trial / NCT02453867
Efficacy and Safety of a Reduced Immunosuppression vs. Standard Triple Therapy in Senior Renal Transplant Recipients
Phase 4
Unknown
400 enrolled
Klemens Budde
Charite University, Berlin, Germany · collabDESCARTES Working Group On Transplantation · collabEuropean Kidney Transplant Association (EKITA) · collabEuropean Renal Association - European Dialysis and Transplant Association · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
Study purpose To establish efficacy and safety of a reduced immunosuppressive therapy with tacrolimus once daily for senior (\>65 years of age) renal transplant recipients
Timeline
- Start
- 2017-12
- Primary completion
- 2018-07
- Completion
- 2019-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mycophenolate Sodium | Unknown | 1 g | — |
| Subject | Mycophenolate Sodium | Unknown | 720 g | — |
| Background | Tacrolimus | Small molecule | — | — |